Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

29.0K
Overview
29.0K
Hypersensitivities01:30

Hypersensitivities

1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Antibody Structure01:10

Antibody Structure

61.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Financial support scheme following a recognised occupational injury].

Ugeskrift for laeger·2026
Same author

Platelets accelerate endoplasmic reticulum stress and promote hepatic steatosis.

JHEP reports : innovation in hepatology·2026
Same author

Impedance Pneumography for Diagnosing and Monitoring Asthma in Young Children: A Systematic Review.

Children (Basel, Switzerland)·2026
Same author

Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Allergy·2026
Same author

Perfluoroalkyl substance exposure and risk of asthma at age 9 years.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Healthcare Professional Survey on Complementary Feeding and Allergy Prevention in High- Versus Low-Risk Infants: An EAACI Task Force Report.

Allergy·2025

Related Experiment Video

Updated: Sep 18, 2025

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.3K

[Hymenoptera venom allergy].

Hans-Jørgen Malling1, Kirsten Skamstrup Hansen1,2, Susanne Halken3

  • 1Klinik for Allergi, Hud- og Kønssygdomme, Københavns Universitetshospital - Herlev og Gentofte Hospital.

Ugeskrift for Laeger
|June 20, 2025
PubMed
Summary
This summary is machine-generated.

Venom immunotherapy (VIT) is recommended for individuals with confirmed insect sting allergies and severe reactions or reduced quality of life. Diagnostics for VIT should be limited to suitable candidates, with treatment typically lasting five years.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.9K

Related Experiment Videos

Last Updated: Sep 18, 2025

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.9K

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine
  • Toxicology

Background:

  • Insect sting hypersensitivity affects numerous individuals globally.
  • Systemic anaphylactic reactions pose significant health risks.
  • Venom immunotherapy (VIT) is a primary treatment for severe insect sting allergies.

Purpose of the Study:

  • To establish clear guidelines for the diagnostic workup and therapeutic indications of VIT.
  • To define patient populations who benefit most from VIT.
  • To provide recommendations on VIT duration and emergency preparedness.

Main Methods:

  • Systematic review of existing literature on venom immunotherapy.
  • Analysis of clinical trial data and expert consensus.
  • Evaluation of diagnostic criteria and treatment outcomes.

Main Results:

  • Diagnostics for VIT should be reserved for patients with confirmed sensitization and systemic reactions or significant quality of life impairment.
  • VIT is not recommended for monosymptomatic urticaria.
  • A five-year duration for VIT is recommended, alongside carrying an adrenaline autoinjector.

Conclusions:

  • VIT is a valuable treatment for specific patient groups with insect sting allergies.
  • Careful patient selection is crucial for effective and safe VIT.
  • Long-term adherence and emergency preparedness are essential components of VIT management.